🇺🇸 FDA
Pipeline program

Xuesaitong Soft Capsule

2023-ZX074

Approved small_molecule active

Quick answer

Xuesaitong Soft Capsule for Coronary Heart Disease is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 2 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Coronary Heart Disease
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials